TY - JOUR AU - Pascual, J AU - Attard, G AU - Bidard, F-C AU - Curigliano, G AU - De Mattos-Arruda, L AU - Diehn, M AU - Italiano, A AU - Lindberg, J AU - Merker, J D AU - Montagut, C AU - Normanno, N AU - Pantel, K AU - Pentheroudakis, G AU - Popat, S AU - Reis-Filho, J S AU - Tie, J AU - Seoane, J AU - Tarazona, N AU - Yoshino, T AU - Turner, N C PY - 2022 DO - 10.1016/j.annonc.2022.05.520 UR - http://hdl.handle.net/10668/21915 T2 - Annals of oncology : official journal of the European Society for Medical Oncology AB - Circulating tumour DNA (ctDNA) assays conducted on plasma are rapidly developing a strong evidence base for use in patients with cancer. The European Society for Medical Oncology convened an expert working group to review the analytical and clinical... LA - en KW - circulating tumour DNA (ctDNA) KW - liquid biopsy KW - precision medicine KW - Biomarkers, Tumor KW - Circulating Tumor DNA KW - Humans KW - Mutation KW - Neoplasm Recurrence, Local KW - Precision Medicine TI - ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. TY - research article VL - 33 ER -